Vivid Financial Management’s Pfizer PFE Stock Holding History

Vivid Financial Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$277K	Buy	+4,689	New	+$232K	0.1%	108

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vivid Financial Management's PFE Position: Q4 2021 in Review

Vivid Financial Management opened a new position in Pfizer (PFE) in Q4 2021: 4,689 shares worth $277K. The stake represents 0.1% of the portfolio and ranks #108 among its holdings.

3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

Vivid Financial Management held 4,689 shares of Pfizer worth $277K as of Q4 2021.
Pfizer was a new Vivid Financial Management position in Q4 2021.
Pfizer made up 0.1% of Vivid Financial Management's portfolio in Q4 2021, its #108 holding.
3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Vivid Financial Management's 13F filing for Q4 2021, filed 21 Jan 2022.